Clinical Trial Update: A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing BAT1706 to EU Avastin in advanced non-squamous non-small cell lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Non-squamous Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• BAT1706 (BAT1706)

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Non-squamous Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2021-09-13